AI Medical Scribe Regulations: What's Coming in 2026 and Beyond

Regulation is catching up to AI documentation

For the past few years, AI medical scribes operated in a regulatory gray area. Not exactly unregulated, but not specifically regulated either. HIPAA covered the data handling. State medical practice acts covered the physician's responsibility for documentation. But nothing addressed the AI itself.

That's changing. Regulators in the US, Canada and the EU are developing frameworks specifically for AI in healthcare. And clinical documentation AI is firmly in their sights.

This isn't a reason to panic. It's a reason to pay attention. The practices and vendors that prepare for regulatory changes now will have a smoother transition than those who scramble later.

The US regulatory picture

FDA positioning

The FDA has been clarifying its stance on AI clinical documentation tools through a series of guidance documents and public statements.

The key distinction the FDA draws is between clinical decision support (CDS) and documentation assistance. AI tools that only document what happened during an encounter, without recommending treatments or influencing clinical decisions, face lighter regulatory oversight. Tools that analyze documentation and suggest diagnoses or treatments fall under stricter CDS regulations.

Most current AI scribes fall into the documentation-only category. But as these tools add features like care gap identification, coding suggestions and clinical alerts, the line between documentation and decision support blurs.

The FDA's proposed framework includes:

• Pre-market review for AI tools classified as clinical decision support devices
• Post-market surveillance requirements for monitoring AI performance after deployment
• Transparency requirements mandating that vendors disclose how their AI models were trained and validated
• Update management protocols for how AI model updates are reviewed and approved

State-level regulation

Several states are moving faster than federal agencies. California, New York and Colorado have proposed or enacted AI transparency laws that affect healthcare AI tools. These laws typically require:

• Disclosure to patients when AI is used in their care
• Algorithmic impact assessments for AI tools that affect health outcomes
• Bias testing and reporting for AI systems used in clinical settings

The patchwork of state regulations creates compliance challenges for AI scribe vendors and the practices that use them. A tool compliant in Texas might not meet California requirements.

HIPAA enforcement updates

OCR (Office for Civil Rights) has signaled increased enforcement attention on AI tools that process protected health information. Specific areas of focus include:

• Whether AI vendors have adequate Business Associate Agreements in place
• How audio recordings of patient encounters are stored, processed and deleted
• Whether AI model training uses de-identified data in compliance with HIPAA's de-identification standards
• Access controls and audit logging for AI-generated documentation

Canadian regulatory developments

Health Canada is developing its own framework for AI in healthcare, influenced by but distinct from the US approach.

The Artificial Intelligence and Data Act (AIDA), part of Bill C-27, establishes a broader AI regulatory framework that includes healthcare applications. Key provisions relevant to AI scribes include:

• Classification of AI systems by risk level, with healthcare applications generally classified as high-risk
• Requirements for human oversight of AI decisions that affect individuals
• Mandatory impact assessments for high-risk AI systems
• Transparency obligations requiring disclosure of AI use to affected individuals

Provincial regulators are adding their own requirements. Ontario's Information and Privacy Commissioner has issued guidance on AI and health privacy that specifically addresses ambient listening technologies in clinical settings.

The Canadian regulatory environment adds complexity for AI scribe vendors because they must comply with federal, provincial and territorial requirements simultaneously.

What physicians should do now

Regulatory changes don't happen overnight, but preparation matters. Here's what practices should be doing:

Document your AI usage policies. Have a written policy that describes how your practice uses AI documentation tools, including patient notification procedures, physician review requirements and error handling processes. Regulators will look for this.

Ensure proper BAAs. Every AI vendor that processes PHI needs a Business Associate Agreement. Review yours to make sure it covers AI-specific scenarios like model training, audio recording retention and data breach notification.

Maintain physician oversight. Every regulatory framework being developed requires human oversight of AI-generated clinical documentation. Physicians must review and approve AI-generated notes before they become part of the medical record. This isn't optional and likely never will be.

Track consent practices. Patient notification about AI recording is becoming legally required in more jurisdictions. Start documenting consent now, even if your state or province doesn't currently require it.

Choose vendors carefully. Ask potential AI scribe vendors about their regulatory preparedness. Do they have a regulatory affairs team? Are they tracking upcoming requirements? Have they been through any certification processes? Vendors who treat regulation as an afterthought will create problems for their customers.

What vendors need to prepare for

AI scribe vendors face the heavier regulatory burden. The most likely requirements include:

• Model validation studies demonstrating accuracy across diverse patient populations
• Bias audits showing the AI performs equitably regardless of patient demographics, accent or language
• Incident reporting systems for documenting and investigating AI errors
• Version control and change management processes for AI model updates
• Data governance documentation showing how training data was sourced, de-identified and maintained

The vendors who view regulation as a competitive advantage rather than a burden will win. Practices want to use tools they can trust, and regulatory compliance builds that trust.

Transcribe Health maintains HIPAA compliance, transparent AI practices, and proactive regulatory preparedness. As regulations evolve, the platform evolves with them to help your practice stay compliant.

---

This article is for informational purposes only and does not constitute legal or compliance advice. Regulatory landscapes change frequently. The information provided reflects general trends as of the publication date and may not capture recent legislative or regulatory developments. Consult with a qualified healthcare regulatory attorney for guidance specific to your organization.